Business Description
Seelos Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US81577F4063
Description
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. Its product pipeline includes SLS-002, SLS-005, SLS-004, SLS-007, and SLS-009.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
12-1 Month Momentum % | -80 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 65.31 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SEELQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Seelos Therapeutics Inc Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -475.52 | ||
| Beta | 50.6522 | ||
| 3-Year Sharpe Ratio | -2.34 | ||
| 3-Year Sortino Ratio | -1.99 | ||
| Volatility % | 80 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | -80 | ||
| 52-Week Range ($) | 0.0001 - 0.01 | ||
| Shares Outstanding (Mil) | 0.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Seelos Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Seelos Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 132 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 41 days | ||
| First quarter earnings results for 2026 | 2026-07-14 | In 10 days | ||
| Annual report for 2025 | 2026-07-07 | In 3 days | ||
| General meeting for 2025 | 2026-07-07 | In 3 days | ||
| General meeting for 2024 | 2024-11-25 08:00 | 0.30 (-41.16%) | ||
| 0.0625:1 Stock Split | 2024-09-27 | 5.00 (-2.34%) | ||
| Second quarter earnings results for 2024 | 2024-08-14 | 3.81 (-7.71%) | ||
| 0.125:1 Stock Split | 2024-05-16 | 37.15 (+14.70%) | ||
| 0.0333333:1 Stock Split | 2023-11-28 | 408.19 (-22.86%) |
Show
Entries
Seelos Therapeutics Inc Frequently Asked Questions
What is Seelos Therapeutics Inc(SEELQ)'s stock price today?
The current price of SEELQ is $0.00. The 52 week high of SEELQ is $0.01 and 52 week low is $0.00.
When is next earnings date of Seelos Therapeutics Inc(SEELQ)?
The next earnings date of Seelos Therapeutics Inc(SEELQ) is 2026-07-14 Est..
Does Seelos Therapeutics Inc(SEELQ) pay dividends? If so, how much?
Seelos Therapeutics Inc(SEELQ) does not pay dividend.
Guru Commentaries on OTCPK:SEELQ
No articles.
Press Release
Articles on Seelos Therapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers